Republicans Seek Probe Into EpiPen's Medicaid Rebate Status
Ellyn Sternfield, a Health Law attorney and Special Counsel in the Mintz Washington, DC office, is quoted in this Bloomberg BNA Health Care Daily Report article. The piece notes claims by congressional Republicans that Medicaid’s classification of EpiPens as “generic,” lowered company rebates paid to the program, and ought to undergo a Health and Human Services Office of Inspector General (OIG) investigation.
Source
Bloomberg BNA Health Care Daily Report